Información:
Error:
ID
27419
Descripción
N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT00637624
Link
https://clinicaltrials.gov/show/NCT00637624
Palabras clave
Versiones (1)
- 14/11/17 14/11/17 -
Titular de derechos de autor
See clinicaltrials.gov
Subido en
14 de noviembre de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Carcinoma, Non-Small-Cell Lung NCT00637624
Eligibility Carcinoma, Non-Small-Cell Lung NCT00637624
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Non-Small-Cell Lung NCT00637624
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Non-Small Cell Lung Carcinoma | Small cell carcinoma of lung | Malignant mesothelioma
Item
diagnose is histologically or cytologically proven (nsclc,sclc), malignant mesothelioma (histologically)
boolean
C0007131 (UMLS CUI [1])
C0149925 (UMLS CUI [2])
C0345967 (UMLS CUI [3])
C0149925 (UMLS CUI [2])
C0345967 (UMLS CUI [3])
Chemotherapy cycle Quantity Planned | Cisplatin
Item
at least 4 cycles of cisplatin are planned
boolean
C1302181 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C0008838 (UMLS CUI [2])
C1265611 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C0008838 (UMLS CUI [2])
Renal function | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
adequate renal function (creatinine clearance as calculated by cockroft-gault method > 60 ml/min)
boolean
C0232804 (UMLS CUI [1])
C2711451 (UMLS CUI [2])
C2711451 (UMLS CUI [2])
Karnofsky Performance Status
Item
karnofsky performance score > 60 %
boolean
C0206065 (UMLS CUI [1])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance | Electromyography | Quality of life Assessment
Item
patient must be able to comply with study measurements i.e. hospital visits for emg and qol assessments
boolean
C0525058 (UMLS CUI [1])
C0013839 (UMLS CUI [2])
C0034380 (UMLS CUI [3,1])
C1516048 (UMLS CUI [3,2])
C0013839 (UMLS CUI [2])
C0034380 (UMLS CUI [3,1])
C1516048 (UMLS CUI [3,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Neuropathy Pre-existing
Item
patients with pre-existing neuropathy
boolean
C0442874 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C2347662 (UMLS CUI [1,2])
NAC Discontinue Unwilling
Item
patients not willing to stop earlier prescribed nac
boolean
C0001047 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C1444662 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
Vitamin E Dosage Discontinue Unwilling | Vitamin A Dosage Discontinue Unwilling
Item
patients not willing to stop vitamins e and a above daily advisory dosage
boolean
C0042874 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,3])
C0558080 (UMLS CUI [1,4])
C0042839 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C1444662 (UMLS CUI [2,3])
C0558080 (UMLS CUI [2,4])
C0178602 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,3])
C0558080 (UMLS CUI [1,4])
C0042839 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C1444662 (UMLS CUI [2,3])
C0558080 (UMLS CUI [2,4])
CNS metastases Uncontrolled | Metastases to peripheral nervous system Uncontrolled
Item
uncontrolled metastasis in the central or peripheral nervous system
boolean
C0686377 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0948131 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0205318 (UMLS CUI [1,2])
C0948131 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])